Latest News and Press Releases

- Orelabrutinib is the first BTK inhibitor to demonstrate significant clinical activity in a Phase 2 clinical trial for SLE - - Zenas acquired the exclusive right to develop, manufacture and...

Kraig Labs (OTCQB: KBLB) produced more than one million BAM-1 Alpha hybrid eggs that will serve as the next wave of recombinant spider silk production

Fondsbørsmeddelelse 65/2025 Djurslands Bank offentliggjorde den 1. september 2025 et aktietilbagekøbsprogram på 35 mio. kr., dog med maksimalt 51.800 aktier. Aktietilbagekøbsprogrammet startede den...

 IND submitted for ABP-102/CT-P72, a HER2 × CD3 T cell engager, with preclinical studies demonstrating enhanced HER2-high tumor selectivity and a favorable safety profile ABP-102/CT-P72 represents...

Pune, India, Dec. 15, 2025 (GLOBE NEWSWIRE) -- The QKS Group SPARK Matrix™ provides competitive analysis & ranking of the leading NDR vendors. InvGate, with its comprehensive InvGate Asset...

Pune, India, Dec. 15, 2025 (GLOBE NEWSWIRE) -- The QKS Group SPARK Matrix™ provides competitive analysis & ranking of the leading CCOS vendors. Progress, with its comprehensive CCOS solution...

Increased self-mining hashrate to 45.7 EH/s on continued deployment of SEALMINERsBitcoin production increased 251% year over year to 526 Bitcoin SINGAPORE, Dec. 15, 2025 (GLOBE NEWSWIRE) --...

MIAMI, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Opendoor Technologies Inc. (Nasdaq: OPEN) today announced two executive appointments designed to accelerate the Company's next phase of growth: President...

Company is on track to file the Phase 3 protocol in the fourth quarter of 2025 SAN FRANCISCO, Dec. 15, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the Office of...

TORONTO, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Guardian Capital LP announces the following regular cash distributions for the period ending December 31, 2025, in respect of the ETF series of the...